HomeResearch Reports

East India Pharmaceutical Works Limited Unlisted Shares

East India Pharmaceutical Works Limited company logo

East India Pharmaceutical Works Limited Share Price

PHYSICAL

PUBLIC LIMITED

Price Chart

1W
1M
1Y
MAX

High

₹126.5

Low

₹48

Return

110.83%

Buy Sell East India Pharmaceutical Works Limited Unlisted Shares

As of November 04, 2026, East India Pharmaceutical Works Unlisted Shares are available at ₹126.50 per share, with a face value of ₹10.00 per share, a 52-week high of ₹126.00 and a 52-week low of ₹100.00. The minimum lot size is 2500 shares, and the shares can be held in dematerialised form through NSDL and CDSL.

ISIN

info icon

INE254X01017

Face Value

info icon

10

Total Shares

info icon

66,74,858

Market Cap

info icon

84.44 Cr

Profit After Tax

info icon

1.69 Cr

Total Revenue

info icon

233.35 Cr

P/E

info icon

49.92

P/B

info icon

1.61

Sector

info icon

Health Care

Sub-sector

info icon

Pharmaceuticals

Category

info icon

Micro Cap

Cashflow - Operations

info icon

-3.11 Cr

About East India Pharmaceutical Works Limited

  • ​East India Pharmaceutical Works Limited is involved in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including generic drugs, branded formulations, and over-the-counter (OTC) medicines, with expertise in various therapeutic areas, including anti-infectives, analgesics, anti-diabetics, respiratory, cardiovascular, gastrointestinal, vitamins and minerals, dermaceuticals, and nutritional supplements.
  • With 85 years of excellence, East India Pharmaceutical Works has dedicated its efforts to envisaging and defining scientific solutions, thereby ushering in a range of revolutionary quality pharmaceutical products catering to the growth and needs of the healthcare industry.
  • The company is focusing on expanding its international presence and exploring new market opportunities. The company is exporting medicines to over 50 countries worldwide, covering regions like Asia, Africa, Europe, Latin America, and North America.
  • East India Pharmaceutical Works developed several first-of-its-kind generic drugs in India, including the first indigenously developed antimalarial drug, the first generic version of metformin (anti-diabetic), and the first generic version of ramipril (anti-hypertensive). The company also has a strong pipeline of new products in development across various therapeutic areas.
  • With the help of consumer understanding and continuous development through advanced research, the company offers over 100 medical products under brands like Enteroquinol, Vitazyme, Locula, Bactiv, Tonoferon, and Pyrigesic to cater to a wide range of healthcare needs.
  • ​East India Pharmaceutical Works Limited is a Public incorporated on 27 April 1936, with its registered office at 6, Nandalal Bose Sarani, Kolkata, WB 700071, IN.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

East India Pharmaceutical Works Limited Media

News

Articles

Videos

No News available for this company.

Frequently Asked Question (FAQs)

Where can I find the annual report of East India Pharmaceutical Works Limited Ltd?

The annual report of East India Pharmaceutical Works Limited Ltd is available in the annual report section.

What is the lock-in period of East India Pharmaceutical Works Limited Unlisted Shares?

Lock-in period of East India Pharmaceutical Works Limited Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of East India Pharmaceutical Works Limited Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of East India Pharmaceutical Works Limited Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.

Is buying East India Pharmaceutical Works Limited Unlisted Shares is legal in India?

Yes, buying and selling of unlisted shares in India is 100% legal.

See More

East India Pharmaceutical Works Limited

₹ 126.5

cartIcon